Skip to content
  • CAT
  • ESP
  • ENG
  • About us
  • Contact
El·lipse
  • instagram
  • twitter
  • flickr
  • linkdin
  • facebook
  • youtube
  • Research
  • Public engagement
  • Scientific life
  • Community
  • About us
  • Contact
  • instagram
  • twitter
  • flickr
  • linkdin
  • facebook
  • youtube
  • CAT
  • ESP
  • ENG

Drug development

16.12.2022

Treatment to improve cognitive function in Down’s syndrome on a clinical trial

19.04.2022

A technique that could revolutionize drug development

29.11.2021

A strategic agreement to accelerate the development of new drugs

cannabis plant and pills
23.07.2021

David Andreu (DCEXS-UPF): “Cannabis co-administered with the drug we have developed would offer analgesia without cognitive side effects”

Iris L. Matilla Vaz es enfermera en la unidad de investigación clínica del IMIM, donde se realizan ensayos clínicos en fase I.
20.05.2021

Iris Lioba Matilla Vaz (IMIM): “Without clinical trials, medicine could not move forward”

Understanding the key role of arrestin in the intracellular signalling process. Image courtesy of GPCR drug discovery .
28.09.2020

Deciphering the cell signalling code: the role of β-arrestins

The last "IMIM Seminars At Home" presented two of the Covid19 projects taking place at the IMIM. One focuses on drug development, the other relies on the immune response.
22.05.2020

Drugs and antibodies: the strategies of two IMIM groups to block SARS-CoV-2

A new study by IMIM researchers will help design safer drugs. Image by Joshua Coleman at Unsplash.
05.11.2019

Inside out: looking within our bodies improves drug design

Manuel Pastor, principal investigator at the pharmacoinformatics group at GRIB.
21.03.2019

Manuel Pastor: “We have created one of the world’s largest toxicology database”

The use of animals, mostly rodents, is nowadays still esential for the development of new drugs to improve human health. Image by Rita Casas/PRBB. CC BY-NC-SA.
13.09.2013

Animals in biomedical research

Ferran Sanz is the director of the Research Programme on Biomedical Informatics (GRIB).
18.10.2011

Ferran Sanz: “Habitual competitors are now working together to get better toxicity predictions”

07.04.2011

David Searls: “Personalised medicine and Big Pharma need bioinformatics”

El·lipse is published by the PRBB Communications and Corporate Relations Area.

Dr Aiguader, 88, 08003 Barcelona, Spain

For any suggestions or collaborations please contact us at ellipse@prbb.org

  • Read past print editions
  • About El·lipse
  • About the PRBB
  • Legal disclaimer
  • instagram
  • twitter
  • flickr
  • linkdin
  • facebook
  • youtube
© 2023 El·lipse, PRBB
  • Home
  • News
  • Our picks
This website uses cookies that provide us with personal information, such as data associated with your browsing. If you click on I AGREE, both we and our Partners can install cookies or access non-sensitive information on your device in order to facilitate the reproduction of content, provide features on social networks, create profiles and compile statistics on traffic and usability in our website. You can get MORE INFORMATION by accessing our COOKIES POLICY. I agree More information
Privacy & Cookies Policy
Necessary Always Enabled

Subscribe to our mailing list
Want to be the first to know everything that goes on at the biggest biomedical research hub in Southern Europe? Subscribe to the el·lipse newsletter!

We will send you an email with the latest news.

See you soon!

You are subscribing to receive the newsletter in English. If you would like to receive it in Catalan or Spanish, please change the language settings in our web.

PRBB will use the information you provide on this form to be in touch with you and to provide updates. By clicking below to subscribe, you accept our privacy policy. You can unsubscribe at any time.